5-HYDROXYTRYPTAMINE RECEPTOR 2A

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Jun 26 16:52:11 UTC 2021` Edited by `admin` on `Sat Jun 26 16:52:11 UTC 2021`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	NQI5D806LC
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

5-HYDROXYTRYPTAMINE RECEPTOR 2A

Common Name

English

5-HT2A

Common Name

English

HTR2

Common Name

English

5-HT-2

Common Name

English

SEROTONIN RECEPTOR 2A

Common Name

English

5-HT2A RECEPTOR

Common Name

English

Code System Code Type Description

UNIPROT

P28223

Created by admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021

PRIMARY

FDA UNII

NQI5D806LC

Created by admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021

PRIMARY

PHAROS

P28223

Created by admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021

PRIMARY

From	To
1_148	1_227
1_349	1_353

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_8
N	1_38
N	1_44
N	1_51
N	1_54

Related Record Type Details


					F42Z27575A

INVERSE AGONIST->TARGET


					UVL329170W

CISAPRIDE

AGONIST -> TARGET


					7W67II88GC

AGONIST -> TARGET


					NUV44L116D

INHIBITOR -> TARGET


					838F01T721

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					E0QN3D755O

LISURIDE

AGONIST -> TARGET


					R8I97I2L24

INHIBITOR -> TARGET


					VPO7KJ050N

INHIBITOR -> TARGET

Interaction Type:

MAJOR

Qualification:

Ki

Amount:


					A1W5INI515

N-METHYLKETANSERIN, (N-METHYL C-11)-

RADIOLIGAND->TARGET


					K2EKD66LRL

RADIOLIGAND->TARGET


					GVV4Z879SP

INHIBITOR -> TARGET


					ES3TWM82E8

INHIBITOR -> TARGET


					A051Q2099Q

INHIBITOR -> TARGET


					21HMQ851IS

INHIBITOR -> TARGET


					ZNP5SNF9FY

SB-773812

INHIBITOR -> TARGET

Amount:


					WUB601BHAA

DIMETHYLTRYPTAMINE

AGONIST -> TARGET

Comments:

all of the tryptamines, including DMT but with the exception of psilocin, were more potent agonists at the 5-HT2A receptor than LSD in the assay that was used in the present study. LSD and psilocin were 5-HT2A receptor partial agonists, with 28% and 16% activation efficacy, respectively, whereas all of the other compounds presented higher 5-HT2A receptor activation efficacies (up to >80% for DiPT and 5-MeO-MiPT).

Qualification:

EC50

Amount:


					O5KFK61E74

ANTAGONIST->TARGET


					TG537D343B

INHIBITOR -> TARGET


					6GVX9S46ZO

ALTANSERIN F-18

RADIOLIGAND->TARGET


					IO7663S6D3

INHIBITOR -> TARGET


					63J9EQ81YC

INHIBITOR -> TARGET


					ZZ7JB9QBU3

CPD-1

AGONIST -> TARGET


					0D21EQAQQA

OSU-6162

PARTIAL AGONIST->TARGET


					5ASJ6HUZ7D

DOXEPIN

INHIBITOR -> TARGET


					2RV7212BP0

AGONIST -> TARGET


					JOQ8SWH63J

SETOPERONE F-18

RADIOLIGAND->TARGET


					X8L60BA01I

PARTIAL AGONIST->TARGET


					QM05G7NM4H

MIN-117 FREE BASE

INHIBITOR -> TARGET


					2YHB6175DO

INHIBITOR -> TARGET


					X3V8LI2TUV

PARTIAL AGONIST->TARGET


					B4J10KD2KI

INHIBITOR -> TARGET


					F6RJL8B278

WEAK INHIBITOR->TARGET

Qualification:

Ki

Amount:


					Z22441975X

INHIBITOR -> TARGET


					19P708E787

INHIBITOR -> TARGET


					L6UH7ZF8HC

3-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					82VFR53I78

INHIBITOR -> TARGET


					00U7GX0NLM

MINAPRINE

INHIBITOR -> TARGET


					J60AR2IKIC

CLOZAPINE

INHIBITOR -> TARGET


					BGL0JSY5SI

INHIBITOR -> TARGET


					U221XI117N

AGONIST -> TARGET


					LER583670J

LOXAPINE

INHIBITOR -> TARGET


					8BA8T27317

INHIBITOR -> TARGET


					9S7OD60EWP

CHLORPROTHIXENE

INHIBITOR -> TARGET


					N7U69T4SZR

INHIBITOR -> TARGET


					XZA9HY6Z98

INHIBITOR -> TARGET


					A9M89XG7QW

2-BROMOMESCALINE

AGONIST -> TARGET


					FAG88V8OKW

DEUTEROALTANSERIN F-18

RADIOLIGAND->TARGET


					5Y7196B0YZ

25C-NBOME HYDROCHLORIDE

AGONIST -> TARGET


					2J3YBM1K8C

INHIBITOR -> TARGET


					T0W602CN0W

R-93274

INHIBITOR -> TARGET


					26HUS7139V

INHIBITOR -> TARGET


					70BSQ12069

ANTAGONIST->TARGET

Interaction Type:

BINDING

Qualification:

Ki

Amount:


					U42B7VYA4P

INHIBITOR -> TARGET


					G905IN29U4

BELOXEPIN

INHIBITOR -> TARGET


					37JK4STR6Z

INHIBITOR -> TARGET


					V68MR69LDZ

KML-010

INHIBITOR -> TARGET


					PR834Q503T

AGONIST -> TARGET


					RG7FY73ZAA

5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE

AGONIST -> TARGET


					R7X848UW5A

PARTIAL AGONIST->TARGET


					22IC88528T

INHIBITOR -> TARGET

Comments:

cell:CHO; ligand: 3-H-KETASERIN

Interaction Type:

BINDING

Qualification:

Ki

Amount:


					5XE4NWM740

INHIBITOR -> TARGET


					JKZ19V908O

ASENAPINE

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					JZ963P0DIK

INVERSE AGONIST->TARGET

Interaction Type:

AGONIST

Qualification:

Ki

Amount:


					BL03SY4LXB

INHIBITOR -> TARGET


					54EJ303F0R

INHIBITOR -> TARGET


					BHS67KQE5Q

3-METHOXY-4-METHYLAMPHETAMINE

AGONIST -> TARGET


					SSW3KY7SWW

25B-NBF

PARTIAL AGONIST->TARGET

Qualification:

Ki

Amount:


					942AS5KEH1

ICI-170809 FREE BASE

INHIBITOR -> TARGET


					6UKA5VEJ6X

INHIBITOR -> TARGET


					69O5WQQ5TI

CYCLOBENZAPRINE

INHIBITOR -> TARGET


					1806D8D52K

INHIBITOR -> TARGET


					L1FV2HFG5F

RADIOLIGAND->TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Molecular Formula	CHEMICAL